Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TGTX US Equity

Tg Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1001316 · FY ends Dec 31
$51.69
+1.43 (+2.85%)
USD · as of 2026-08-19 · marketstack
9 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-128-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-06-038-K 8.01Other eventssec.gov ↗
2026-05-278-K 8.01Other eventssec.gov ↗
2026-05-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD PORTFOLIO MANAGEMENT LLCsec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-208-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-03-208-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-02-268-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-138-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-1013GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2025-11-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-03

Every row is a filed document, checked against its EDGAR index.